• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种β受体阻滞剂的即刻效应比较:一种是非选择性的,另一种是对运动诱发型心绞痛具有适度内在拟交感活性的心脏选择性β受体阻滞剂。

Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.

作者信息

Berkenboom G M, Ibrahim T, Abramowicz M, Degre S G

出版信息

Cardiology. 1987;74(1):43-8. doi: 10.1159/000174173.

DOI:10.1159/000174173
PMID:2880663
Abstract

To compare the effects of two beta-blocking drugs: a nonselective (propranolol) and a cardioselective with modest intrinsic sympathomimetic activity (visacor), 24 patients with stable angina pectoris performed a control exercise (without medication) on a bicycle ergometer (increments of 30 W every 3 min), and thereafter were randomized to receive either propranolol (40 mg t.i.d.) or visacor (200 mg once daily) for a 48-hour double-blind trial. The 2 groups on control exercise were similar with regard to their exercise tolerance: 7.6 +/- 2.3 versus 7.1 +/- 1.4 min (NS) and the behavior of heart rate, systolic, diastolic blood pressure and double product, at rest and during exercise. They exercised on the 2nd day 2 h after the intake of propranolol or visacor. In the 12 patients randomized to propranolol, heart rate, systolic and diastolic pressures, double product were significantly reduced at rest, compared with control exercise: 67 +/- 8 versus 81 +/- 10 beats/min (p less than 0.01), 132 +/- 20 versus 146 +/- 21 mm Hg (p less than 0.02), 80 +/- 8 versus 88 +/- 10 mm Hg (p less than 0.02), 8,828 +/- 1,927 versus 11,863 +/- 2,138 mm Hg X min-1 (p less than 0.001), respectively. On the contrary, in the 12 patients randomized to visacor, these parameters at rest were less modified and only heart rate was significantly decreased: 71 +/- 9 versus 81 +/- 11 beats/min (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为比较两种β受体阻滞剂的效果:一种是非选择性的(普萘洛尔)和一种具有适度内在拟交感活性的心脏选择性药物(维沙可),24例稳定型心绞痛患者在自行车测力计上进行对照运动(不服药)(每3分钟增加30瓦),然后随机分为接受普萘洛尔(40毫克,每日三次)或维沙可(200毫克,每日一次)进行48小时双盲试验。两组对照运动时的运动耐力相似:分别为7.6±2.3分钟和7.1±1.4分钟(无显著性差异),静息及运动时心率、收缩压、舒张压和双乘积的表现也相似。他们在服用普萘洛尔或维沙可后2小时的第二天进行运动。在随机接受普萘洛尔的12例患者中,与对照运动相比,静息时心率、收缩压和舒张压、双乘积显著降低:分别为67±8次/分钟对81±10次/分钟(p<0.01),132±20毫米汞柱对146±21毫米汞柱(p<0.02),80±8毫米汞柱对88±10毫米汞柱(p<0.02),8828±1927毫米汞柱·分钟-1对11863±2138毫米汞柱·分钟-1(p<0.001)。相反,在随机接受维沙可的12例患者中,这些静息参数变化较小,仅心率显著降低:71±9次/分钟对81±11次/分钟(p<0.05)。(摘要截短至250字)

相似文献

1
Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.两种β受体阻滞剂的即刻效应比较:一种是非选择性的,另一种是对运动诱发型心绞痛具有适度内在拟交感活性的心脏选择性β受体阻滞剂。
Cardiology. 1987;74(1):43-8. doi: 10.1159/000174173.
2
Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.依泮洛尔与美托洛尔治疗心绞痛的疗效比较:瑞典一项运动耐量多中心研究报告
J Intern Med. 1992 Jan;231(1):7-11. doi: 10.1111/j.1365-2796.1992.tb00491.x.
3
Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.钙通道阻滞剂作为稳定型心绞痛的主要治疗方法。维拉帕米与普萘洛尔的双盲安慰剂对照比较。
Am J Cardiol. 1982 Nov;50(5):1158-63. doi: 10.1016/0002-9149(82)90437-4.
4
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.口服普萘洛尔与维拉帕米治疗合并系统性高血压和心绞痛的比较。一项安慰剂对照双盲随机交叉试验。
Am J Cardiol. 1982 Nov;50(5):1164-72. doi: 10.1016/0002-9149(82)90438-6.
5
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.ICI 141,292(Visacor)的初步临床经验,一种具有内源性拟交感活性的新型选择性β1肾上腺素受体阻滞剂——一项针对59例患者的多中心试验。
Br J Clin Pharmacol. 1984 Dec;18(6):831-6. doi: 10.1111/j.1365-2125.1984.tb02552.x.
6
[Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].普萘洛尔与塞利洛尔治疗稳定型劳力性心绞痛的双盲、安慰剂对照试验:抗心绞痛疗效及副作用
Wien Klin Wochenschr. 1982 May 14;94(10):258-61.
7
Safety and efficacy of esmolol for unstable angina pectoris.艾司洛尔治疗不稳定型心绞痛的安全性和有效性。
Am J Cardiol. 1988 Nov 15;62(16):1033-7. doi: 10.1016/0002-9149(88)90543-7.
8
The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Clin Cardiol. 1992 Aug;15(8):591-5. doi: 10.1002/clc.4960150808.
9
A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris.一种新型水溶性、具有内在拟交感活性的选择性β受体阻滞剂(ICI 141.292)用于治疗心绞痛。
Acta Med Scand. 1988;223(1):35-43. doi: 10.1111/j.0954-6820.1988.tb15762.x.
10
Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.用吲哚洛尔治疗心绞痛:β受体阻滞剂内在拟交感活性的意义。
Am Heart J. 1982 Aug;104(2 Pt 2):496-504. doi: 10.1016/0002-8703(82)90146-6.

引用本文的文献

1
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.依泮洛尔(一种具有β1激动剂活性的β1选择性受体阻滞剂)的适度降压作用:静息及运动时的急性和长期血流动力学研究以及与阿替洛尔在动态血压方面的双交叉比较
Cardiovasc Drugs Ther. 1993 Feb;7(1):125-32. doi: 10.1007/BF00878321.
2
Beta-adrenoceptor blockade and exercise. An update.β-肾上腺素能受体阻滞剂与运动。最新进展。
Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002.
3
Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
Drugs. 1989;38 Suppl 2:55-60. doi: 10.2165/00003495-198900382-00014.
4
Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.部分激动剂活性对慢性稳定性心绞痛患者β受体阻滞剂副作用的影响。
Drugs. 1989;38 Suppl 2:39-44. doi: 10.2165/00003495-198900382-00009.
5
Clinical pharmacology of epanolol. Pharmacodynamic aspects.依帕诺洛尔的临床药理学。药效学方面。
Drugs. 1989;38 Suppl 2:18-27. doi: 10.2165/00003495-198900382-00006.
6
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?β-肾上腺素能受体部分激动剂:心血管治疗的复兴?
Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x.